Therapeutic advantages of third generation antihistamines

Expert Opinion on Investigational Drugs

Volumn 7, Issue 7, 1998, Pages 1045-1054

  Handley, D A ^a   Magnetti, A ^a   Higgins, A J ^a  

^a SUNOVION PHARMACEUTICALS INC   (United States)

Author keywords

Active metabolite; Allergic rhinitis; Antihistamine; Astemizole; Fexofenadine; Loratadine; QT prolongation; Terfanadine; Torsades de pointes

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; DRUG METABOLITE; FEXOFENADINE; HISTAMINE RECEPTOR; LORATADINE; NON PRESCRIPTION DRUG; NORASTEMIZOLE; TERFENADINE;

ALLERGIC RHINITIS; ALLERGY; BLOOD BRAIN BARRIER; CARDIOTOXICITY; CHRONIC URTICARIA; COMMON COLD; HEART ARRHYTHMIA; HUMAN; REVIEW; SEDATION;

EID: 0031902480     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.7.1045     Document Type: Review

References (46)